디에틸카르바마진 시트르산염

용도

• Treatment of ascarids
• Heartworm prophylaxis
• Treatment of early stages of Dictyocaulus viviparous infestations
• Heartworm prophylaxis
• Heartworm prophylaxis
• Heartworm prophylaxis
• Heartworm prophylaxis
• Treatment of ascarids
• Treatment of lungworms (Crenosoma vulpis)

투여 방법

가능한 부작용

• Vomiting
• Diarrhea
• Fixed drug eruptions (rare)
• Severe anaphylactoid reaction (in microfilaremic dogs)
• Hepatic injury (reported in cats)

주의사항 및 금기

• Dogs with circulating microfilaria (due to risk of severe shock-like reaction)
• > **CRITICAL WARNING**: DEC is strictly contraindicated in dogs with circulating microfilariae. * Administration to microfilaremic dogs can trigger a severe, potentially fatal **anaphylactoid (shock-like) reaction** within 20 minutes to 2 hours. Signs include salivation, vomiting, ataxia, shock, and DIC. * Always verify a negative heartworm test (specifically checking for microfilaria) before initiating therapy. * If microfilaria are detected in dogs undergoing adulticide therapy while on DEC, stop DEC immediately until microfilaria are eliminated. * Rare reports of infertility in male dogs exist, though controlled studies show no adverse effects on semen.

약물 상호작용

• Pyrantel: Theoretical enhancement of toxic effects due to shared nicotine-like mechanism of action; use with intensified monitoring.
• Morantel: Theoretical enhancement of toxic effects due to shared nicotine-like mechanism of action; use with intensified monitoring.
• Levamisole: Theoretical enhancement of toxic effects due to shared nicotine-like mechanism of action; use with intensified monitoring.

자주 묻는 질문